Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
National Institute of Allergy and Infectious Disease, Warren G. Magnuson Clinical Center of the National Institutes of Health, Maryland 20892-1180, USA.
- Published Article
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
- Publication Date
Feb 28, 2006
Abnormal FDG accumulation occurs in nodes of subjects with detectable viral loads. Interruption of effective ART results in activation of previously quiescent nodal areas.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/18/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/16470113